The Library
A research house and a commercial division
Why the vendor and the laboratory are kept in separate rooms, all the way down to the prose, and what is allowed to cross between them.
SigmaClava is a research house. OccultOpes, its development division for commercial engagements, is a vendor. Keeping those two identities in separate rooms is a structural decision, and this note explains it. Separate sites, separate registers, separate promises.
The corruption we are avoiding
When a research organization and its commercial arm share one voice, each corrupts the other's incentives.
Research starts choosing questions that make good case studies. Sales starts borrowing the credibility of inquiry for claims that are really pitches. The reader can no longer tell which sentences are findings and which are marketing, so, rationally, they trust neither.
The failure is not that anyone lied. It is that a single voice cannot carry two different warranties. A finding says this survived testing and here is where it breaks. A pitch says this will work for you. Put them in the same paragraph and the weaker warranty wins, because a reader has no way to sort them.

Two ordered fields that do not mix, and the single aperture between them. Capability crosses in one direction; the research voice does not cross at all.
The cure is architectural
The cure is architectural, not rhetorical. Editorial intent does not survive a quarter of commercial pressure; structure does.
This site carries no client names, no case studies, no pricing, and exactly one commercial pointer. OccultOpes carries the entire vendor apparatus, covering services, engagement mechanics and delivery practices, and does not claim to be a laboratory. One family; separate mandates, all the way down to the prose.
What flows across, and what does not
What flows from research to commerce is capability with its discipline attached. OccultOpes builds custom software, automation, and applied AI for owner-led businesses, and it works the way the house thinks: an assessment before any proposal, findings delivered in plain language with no obligation, systems built incrementally in visible weekly steps, then stewarded rather than abandoned. Nothing deployed before it is understood; nothing running without a human answerable for it.1
What does not flow across is the research voice. No engagement will ever be cited here as evidence. Applied work informs the questions, and deployments across Dallas, the Emirates, and Colombo keep the house honest about how differently the same system lands in different lives. The Library still publishes only what stands on its own, stripped of anyone's name.
The rule stated plainly: a client can commission a system. A client cannot commission a finding.
The direction that is easy to get wrong
It is worth being explicit about which way the influence is allowed to run.
Commercial work is allowed to raise questions for the research house. A pattern seen across several engagements is a legitimate reason to start looking at something.
Commercial work is not allowed to answer them. An engagement is not a study: the sample is chosen by who paid, the conditions are set by delivery pressure, and the person reporting the outcome has an interest in it. Those are exactly the conditions under which a result is worthless as evidence, however useful the system was to the client.
Why a diligence reader should care
OccultOpes is a DBA of SigmaClava LLC, so anyone vetting the vendor will eventually land on this site.
What they should conclude is exactly what the structure shows: the entity behind the vendor thinks in decades, publishes reluctantly, and holds its commercial work to the standards of its research.
The separation is not distance. It is discipline.
Notes
- 1This is the third principle, named, bounded, and answerable, restated in commercial terms. A principle that changes wording when money is involved was never a principle. ↩